Organon & Co
OGN
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Organon & Co. (Organon) is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. Organon has a portfolio of contraception and fertility brands, such as Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. The Company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. It operates approximately six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 4 days ago • OGN
CUPE 37 Members Reject City of Calgary Wage PackageBusiness Wire • 4 days ago • OGN
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14Zacks Investment Research • 6 days ago • OGN
5 Relative Price Strength Stocks With Strong Return PotentialZacks Investment Research • 13 days ago • OGN
Is Stagflation Round the Corner? 3 Ultra-Safe PicksZacks Investment Research • 14 days ago • OGN
Surging Earnings Estimates Signal Upside for Organon (OGN) StockCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.